-
Mashup Score: 0
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors
Source: jtd.amegroups.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Dimitrios Kelekis Athenian Days of Interventional Oncology 2022 - 2 year(s) ago
Watch on Demand the Dimitrios Kelekis Athenian Days of Interventional Oncology 2022, that wil…
Source: www.livemedia.grCategories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to an exciting meeting next week in Athens, Greece! ADIO 2022: “DIMITRIOS KELEKIS”ATHENIAN DAYS OF INTERVENTIONAL ONCOLOGY. Registration is free at https://t.co/mvGDsBvaWC. #irad #interventionaloncology #GreekIR @SIO_Central @SIRspecialists @cirsesociety @Askemed https://t.co/9uGn2IWu3W
-
-
Mashup Score: 2
Purpose of Review Intrahepatic cholangiocarcinoma (iCCA) carries a dismal prognosis and, despite increasing incidence, still lacks effective treatments. In this scenario, locoregional therapies (LRT) are gaining interest as they may be effective at local tumor control and complementary to surgical and non-surgical approaches. In this article, we will review the evolving role of LRT performed by…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in Current Oncology Reports! This article by Dr. Yifan Wang of @Yale_IR reviews the current role of locoregional therapy in intrahepatic cholangiocarcinoma management. Understanding how to best treat this deadly #cancer is required! #irad https://t.co/emjWs95vU9 https://t.co/5XCp6sISBk
-
-
Mashup Score: 1
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 1: a guide to decision-making
Source: jtd.amegroups.comCategories: Hem/Oncs, Latest HeadlinesTweet-
So awesome to see our recent Journal of Thoracic Disease article referenced during todays excellent, informative "@SIO_Central Meets @sobrice" #lungcancer session in São Paulo! Didn't take long to have worldwide influence from @YaleCancer & @YaleMed! https://t.co/v4wibJZ8ip https://t.co/GJ8tKuewzn
-
-
Mashup Score: 8Therapeutic US Applications for the Abdomen and Pelvis - 2 year(s) ago
US and MRI-guided therapeutic US (TUS) can aid in the treatment of prostate, liver, and pancreatic cancer, as well as uterine fibroids and osseous metastases, and understanding the selection and op…
Source: RadioGraphicsCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @LetDdiceFlyHigh: Therapeutic US Applications for Abdomen/Pelvis https://t.co/oHygFgJ7yD Please read this multimedia rich publication le…
-
-
Mashup Score: 7SOBRICE 2022 - 2 year(s) ago
ABOUT WORKSHOP cTACE COMMITTEE SPEAKERS PROGRAM REGISTRATION PAPER SUBMISSION INTERDISCIPLINARY CONNECTION ACCOMMODATION CONTACT US CONGRESS SITE SÃO PAULO HOME
Source: sobrice2022.com.brCategories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to a interesting session at next week's 25th SOBRICE in São Paulo! @DieHCCDie & I will share our clinical experiences treating various solid tumors w/Neuwave's Microwave Ablation System. See ya' there! #irad #interventionaloncology https://t.co/4JpSW8rTQf https://t.co/L70y686MHU
-
-
Mashup Score: 0Role of Interventional Radiology in Pediatric Cancer Patients - Current Oncology Reports - 2 year(s) ago
Purpose of Review Pediatric interventional radiology (IR) is a growing subspecialty. Here, we review the current role of IR in children with cancer, which uses imaging such as ultrasound, fluoroscopy, and computed tomography to perform minimally invasive procedures. These include biopsy, needle localization, central venous access, thermal ablation, transarterial chemoembolization, transarterial…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in Current Oncology Reports! Superb article by @AguadoAllison from @Nemours on role of #irad in #pediatriccancer! Pediatric patients also may require biopsies, central venous access, locoregional therapy & supportive care. @AmerAcadPeds https://t.co/dxkZL2uT74 https://t.co/txMLSPwyA6
-
-
Mashup Score: 2Study Says Machine Learning MRI Model May Help Predict Recurrence Risk of Hepatocellular Carcinoma - 2 year(s) ago
Noting that the machine learning model incorporating magnetic resonance imaging (MRI) had a higher mean area under the curve (AUC) than a model based solely on clinical features for predicting hepatocellular carcinoma recurrence, researchers said the study findings could have implications for refining liver transplant criteria.
Source: Diagnostic ImagingCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Dx_imaging: Can a #MachineLearning #MRI Model Help Predict Recurrence Risk of Hepatocellular Carcinoma? https://t.co/sHF3rvlSQk @ACRRFS…
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Hot off the press in Current Oncology Reports! Excellent article by Dr. Camacho et al reviews role of #irad & #hepatology in management of #cancer patients w/portal HTN. Highly beneficial in improving QoL but strategies underutilized in patient population. https://t.co/zv3MeXKorI https://t.co/JXGOPrKZLj
-
-
Mashup Score: 0Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma - 2 year(s) ago
There are challenges associated with biomarker testing in patients with cancer, including rare cancers such as intrahepatic cholangiocarcinoma. This article out
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in @OncJournal! An "Expert, Multidisciplinary Perspective on Best Practices in #Biomarker Testing in Intrahepatic #Cholangiocarcinoma." Better understanding of this deadly #cancer required. Thanks to all who contributed! #biopsy #irad https://t.co/KSneg7a2yo https://t.co/BEUUjS9iBk
-
First Brazil, now Greece! Another of our recent Journal of Thoracic Disease articles was referenced during today's superb session on #lungcancer at the Athenian Days of #InterventionalOncology 2022! Global influence from @YaleCancer & @YaleMed continues! https://t.co/oAZZ0DpaFa https://t.co/BTXLXSxv7i